|
Time |
Topic |
Speaker |
Moderator |
|
07:30~08:00 |
Registration |
|
08:00~08:10 |
Opening remarks |
Miin-Fu Chen 陳敏夫 |
|
－Session I
|
|
08:10~09:00 |
Mr. Wang Chang-Gung Memorial Lecture:
Diagnostic
autoantibodies to tumor antigens |
Samir Hanash (USA) |
Sen-Yung Hsieh 謝森永 |
|
09:00~09:35 |
Keynote speech (1):
An
integrative approach to biomarkers discovery and validation for
hepatocellular carcinoma |
John M Luk 陸滿清 (HK, China) |
You-Chen Chao 趙有誠 |
|
09:35~10:10 |
Keynote speech (2):
Discovery of Tumor Biomarkers and Differential Diagnostic Pattern of
Hepatocellular Carcinoma by Proteome Analysis |
Yinkun Liu 劉銀坤 （China） |
Cheng-Yuan Peng 彭成元 |
|
10:10~10:30 |
Coffee Break |
|
－Session II
|
|
10:30~11:05 |
Keynote speech (3):
Finding
biomarkers and therapeutic targets for human hepatocellular carcinoma
by proteomic profiling |
Kazuyuki Nakamura (Japan) |
Chih-Cheng Chien 簡志誠
Teh-Ia Huo 霍德義 |
|
11:05~11:25 |
Liver
Proteomics Research at ITRI- From Database of Proteomes to Biomarker
Development |
Tzu-Ling Tseng 曾錙翎 |
|
11:25~11:45 |
Proteomic Identification of Novel Biomarkers Related to Helicobacter
pylori-associated Gastroduodenal Diseases |
Ming-Shiang Wu 吳明賢 |
|
11:45~12:05 |
Functional Proteomics on human hepatoma: profiling the proteome
dynamics during cell cycle in human hepatoma cells |
Sen-Yung Hsieh 謝森永 |
|
12:05~12:25 |
Differential expression of potential biomarkers in human lung cancer |
Shui-Tein Chen 陳水田 |
|
12:25~13:15 |
Lunch |
|
－Session III
|
|
13:15~13:45 |
Surveillance of hepatitis and hepatocellular carcinoma in carrier
clinic: a 24-year experience |
Dar-In Tai 戴達英 |
Ming-Whei Yu 于明暉 |
|
13:45~14:35 |
Recent advances of non-surgical and multi-modal treatment for early
and advanced hepatocellular carcinoma |
Masatoshi Tanaka (Japan) |
Chaur-Shine Wang 王朝欣 |
|
14:35~14:55 |
Radiofrequency ablation using a modified algorithm and for HCC in
difficult-to-treat locations |
Shi-Ming Lin 林錫銘 |
Guan-Tam Huang 黃冠棠 |
|
14:55-15:15 |
Coffee Break |
|
－Session IV
|
|
15:15-15:40 |
Sequential Preoperative Transcatheter Arterial Chemoembolization rise
effective for Hepatocellular Carcinoma
|
Chian-Fu Hung 洪建福 |
Tze-Yu Lee 李子瑜 |
|
15:40-16:10 |
Current Status of Molecular Targeted Therapy for Hepatotcellular
Carcinoma |
Ann-Lii Cheng 鄭安理 |
Jaw-Ching Wu 吳肇卿 |
|
16:10-16:40 |
Hepatocelluar Carcinoma and Angiogenesis |
Pei-Jer Chen 陳培哲 |
Deng-Yn Lin 林燈寅 |
|
16:40-17:05 |
Anti-viral Therapy for Chronic Hepatitis B and HCC Prevention |
Rong-Nan Chien 簡榮南 |
Jia-Horng Kao 高嘉宏 |
|
17:05-17:55 |
High
Intensity Focused Ultrasound Ablation: A Novel Treatment for Patients
with Liver Cancer |
Feng Wu 伍 烽 |
Chung-Kwe Wang 王鐘貴 |
|
17:55-18:00 |
Closing remarks |
Deng-Yn Lin 林燈寅 |